Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions
Clinical trial NCT00324116 · COMPLETED
Trial details
- NCT number
- NCT00324116
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2008-08-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.